🔗 Permalink

Inventor profile of:

Michael R. Jackson

City:

Del Mar, California

Country:

United States

Published Applications:

Last publication date:

2025-06-26

Top Assignees for applications by Michael R. Jackson

The entities that hold a legal rights for patent applications filed by inventor Jackson Michael R.:

Ortho-McNeil Pharmaceutical Corp. 7 Raritan, NJ United States
The Scripps Research Institute 3 La Jolla, CA United States
JANSSEN PHARMACEUTICALS, INC. 2 Titusville, NJ United States
Ortho-McNeil Pharmaceutical, Inc. 2 Raritan, NJ United States
Ortho-McNeil Pharmaeutical, Inc. 1 Raritan, NJ United States
Ortho Pharmaceutical Corporation 1 Raritan, NJ United States

Recent patent applications by Jackson Michael R.

Michael R. Jackson from Del Mar, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-06-26

US20250205315A1

Human necessities

RECOMBINANT TMEM2 EXTRACELLULAR DOMAIN AND USES THEREOF

#2 | 2011-03-17

US20110065187A1

Human necessities

Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease

#3 | 2011-03-17

US20110065186A1

Human necessities

Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease

#4 | 2011-03-17

US20110065180A1

Human necessities

EX-VIVO PRIMING FOR GENERATING CYTOTOXIC T LYMPHOCYTES SPECIFIC FOR NON-TUMOR ANTIGENS TO TREAT AUTOIMMUNE AND ALLERGIC DISEASE

#5 | 2011-02-03

US20110027301A1

Human necessities

Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease

#6 | 2011-01-27

US20110021747A1

Human necessities

IgE antigenic peptides

#7 | 2011-01-27

US20110020309A1

Human necessities

Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease

#8 | 2011-01-20

US20110015370A1

Human necessities

Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease

#9 | 2010-10-12

US10144188

Isolated CD8 T lymphocytes specifically cytotoxic for a disease causing target cell

#10 | 2009-12-10

US20090305418A1

Chemistry; metallurgy

Cell therapy method for the treatment of tumors

#11 | 2009-08-13

US20090202506A1

Human necessities

Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease

#12 | 2009-01-01

US20090004142A1

Chemistry; metallurgy

Cell therapy method for the treatment of tumors

#13 | 2007-05-03

US20070098734A1

Human necessities

Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease

#14 | 2006-10-24

US10785472

Purification of antigen-specific T cells

#15 | 2006-07-11

US9715891

MHC class II antigen-presenting systems and methods for activatind CD4+T cells

#16 | 2006-06-22

US20060134125A1

Human necessities

Purification of antigen-specific T cells

#17 | 2005-03-17

US20050059144A1

Chemistry; metallurgy

MHC class II antigen-presenting systems and methods for activating CD4T cells

#18 | 2005-03-10

US20050054090A1

Chemistry; metallurgy

MHC class II antigen-presenting systems and methods for activating CD4T cells

InventorID:

3331750 ⎘